The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Open accessAbstract
BACKGROUND: The main objective of individualization of treatment in IVF is to offer every single woman the best treatment tailored to her own unique characteristics, thus maximizing the chances of pregnancy and eliminating the iatrogenic and avoidable risks resulting from ovarian stimulation. Personalization of treatment in IVF should be based on the prediction of ovarian response for every individual. The starting point is to identify if a woman is likely to have a normal, poor or a hyper response and choose the ideal treatment protocol tailored to this prediction. The objective of this review is to summarize the predictive ability of ovarian reserve markers, such as antral follicle count (AFC) and anti-Mullerian hormone (AMH), and the therapeutic strategies that have been proposed in IVF after this prediction. METHODS: A systematic review of the existing literature was performed by searching Medline, EMBASE, Cochrane library and Web of Science for publications in the English language related to AFC, AMH and their incorporation into controlled ovarian stimulation (COS) protocols in IVF. Literature available to May 2013 was included. RESULTS: The search generated 305 citations of which 41 and 25 studies, respectively, reporting the ability of AMH and AFC to predict response to COS were included in this review. The literature review demonstrated that AFC and AMH, the most sensitive markers of ovarian reserve identified to date, are ideal in planning personalized COS protocols. These sensitive markers permit prediction of the whole spectrum of ovarian response with reliable accuracy and clinicians may use either of the two markers as they can be considered interchangeable. Following the categorization of expected ovarian response to stimulation clinicians can adopt tailored therapeutic strategies for each patient. Current scientific trend suggests the elective use of the GnRH antagonist based regimen for hyper-responders, and probably also poor responders, as likely to be beneficial. The selection of the appropriate and individualized gonadotrophin dose is also of paramount importance for effective COS and subsequent IVF outcomes. CONCLUSION: Personalized IVF offers several benefits; it enables clinicians to give women more accurate information on their prognosis thus facilitating counselling especially in cases of extremes of ovarian response. The deployment of therapeutic strategies based on selective use of GnRH analogues and the fine tuning of the gonadotrophin dose on the basis of potential ovarian response in every single woman can allow for a safer and more effective IVF practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Daya, S., Maheshwari, A., Siristatidis, C. S., Bhattacharya, S., & Gibreel, A. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001299 · Cited by 114
RetractedFerraretti, A. P., La Marca, A., Fauser, B. C. J. M., Tarlatzis, B., Nargund, G., Gianaroli, L., & on behalf of the ESHRE working group on Poor Ovarian Response Definition (2011) · Human Reproduction · doi:10.1093/humrep/der092 · Cited by 1,882
Self-citationWeenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
A systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Self-citationSerum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Sunkara, S. K., Rittenberg, V., Raine-Fenning, N., Bhattacharya, S., Zamora, J., & Coomarasamy, A. (2011) · Human Reproduction · doi:10.1093/humrep/der106 · Cited by 924
Self-citationScreening for fetal aneuploidies at 11 to 13 weeks
Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2637 · Cited by 642
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001750.pub4 · Cited by 600
Correlation of ovarian reserve tests with histologically determined primordial follicle number
Hansen, K. R., Hodnett, G. M., Knowlton, N., & Craig, L. B. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.006 · Cited by 534
An OHSS-Free Clinic by segmentation of IVF treatment
Devroey, P., Polyzos, N. P., & Blockeel, C. (2011) · Human Reproduction · doi:10.1093/humrep/der251 · Cited by 514
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
Fauser, B. C. J. M., & van Heusden, A. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0290 · Cited by 509
Toner, J. P., Philput, C. B., Jones, G. S., & Muasher, S. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54249-6 · Cited by 496
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Broer, S. L., Dolleman, M., Opmeer, B. C., Fauser, B. C., Mol, B. W., & Broekmans, F. J. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq034 · Cited by 485
Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J. C., Mol, B.-W. J., Broekmans, F. J. M., on behalf of the IMPORT study group, et al. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms041 · Cited by 457
Self-citationThe antral follicle count: practical recommendations for better standardization
Broekmans, F. J. M., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.040 · Cited by 414
Nelson, S. M., Yates, R. W., & Fleming, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem204 · Cited by 391
Jeppesen, J. V., Anderson, R. A., Kelsey, T. W., Christiansen, S. L., Kristensen, S. G., Jayaprakasan, K., Raine-Fenning, N., Campbell, B. K., & Yding Andersen, C. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat024 · Cited by 374
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2008) · Human Reproduction · doi:10.1093/humrep/den480 · Cited by 339
Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies
Chang, M.-Y., Chiang, C.-H., Hsieh, T.-T., Soong, Y.-K., & Hsu, K.-H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00557-8 · Cited by 327
La Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., & Volpe, A. (2007) · Human Reproduction · doi:10.1093/humrep/del421 · Cited by 327
Self-citationPreventing ovarian hyperstimulation syndrome: guidance for the clinician
Humaidan, P., Quartarolo, J., & Papanikolaou, E. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.028 · Cited by 321
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
Humaidan, P., Kol, S., Papanikolaou, E., & on behalf of the 'The Copenhagen GnRH Agonist Triggering Workshop Group' (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr008 · Cited by 321
Hazout, A., Bouchard, P., Seifer, D. B., Aussage, P., Junca, A. M., & Cohen-Bacrie, P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.061 · Cited by 317
Why do couples drop-out from IVF treatment? A prospective cohort study
Verberg, M. F. G., Eijkemans, M. J. C., Heijnen, E. M. E. W., Broekmans, F. J., de Klerk, C., Fauser, B. C. J. M., & Macklon, N. S. (2008) · Human Reproduction · doi:10.1093/humrep/den219 · Cited by 315
Kolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., & Griesinger, G. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml038 · Cited by 306
Muttukrishna, S., McGarrigle, H., Wakim, R., Khadum, I., Ranieri, D. M., & Serhal, P. (2005) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00670.x · Cited by 304
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles
Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier-Lechner, E., & Tews, G. (2006) · Human Reproduction · doi:10.1093/humrep/del127 · Cited by 281
Lee, T.-H., Liu, C.-H., Huang, C.-C., Wu, Y.-L., Shih, Y.-T., Ho, H.-N., Yang, Y.-S., & Lee, M.-S. (2007) · Human Reproduction · doi:10.1093/humrep/dem254 · Cited by 279
Nardo, L. G., Gelbaya, T. A., Wilkinson, H., Roberts, S. A., Yates, A., Pemberton, P., & Laing, I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.127 · Cited by 266
Jayaprakasan, K., Campbell, B., Hopkisson, J., Johnson, I., & Raine-Fenning, N. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.042 · Cited by 261
Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., Gal, M., Zylber-Haran, E., & Margalioth, E. J. (2005) · Human Reproduction · doi:10.1093/humrep/dei203 · Cited by 255
Early follicular antimüllerian hormone as an indicator of ovarian reserve
Fiçicioǧlu, C., Kutlu, T., Baglam, E., & Bakacak, Z. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.019 · Cited by 248
Pandian, Z., McTavish, A. R., Aucott, L., Hamilton, M. P., & Bhattacharya, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004379.pub3 · Cited by 241
The poor responder in IVF: is the prognosis always poor? A systematic review
Oudendijk, J. F., Yarde, F., Eijkemans, M. J. C., Broekmans, F. J. M., & Broer, S. L. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr037 · Cited by 230
Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg043 · Cited by 227
Relevance of anti-Mullerian hormone measurement in a routine IVF program
Gnoth, C., Schuring, A. N., Friol, K., Tigges, J., Mallmann, P., & Godehardt, E. (2008) · Human Reproduction · doi:10.1093/humrep/den108 · Cited by 225
Fauser, B. C. J. M., Diedrich, K., & Devroey, P. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmm034 · Cited by 221
Biomarkers of ovarian response: current and future applications
Nelson, S. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.11.051 · Cited by 220
Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve
Kwee, J., Schats, R., McDonnell, J., Themmen, A., de Jong, F., & Lambalk, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1293 · Cited by 201
Klinkert, E. R., Broekmans, F. J. M., Looman, C. W. N., Habbema, J. D. F., & te Velde, E. R. (2005) · Human Reproduction · doi:10.1093/humrep/deh663 · Cited by 199
Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J. A., & Balasch, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh718 · Cited by 199
Popovic-Todorovic, B. (2003) · Human Reproduction · doi:10.1093/humrep/deg181 · Cited by 196
Anti‐müllerian hormone as a marker of ovarian reserve*
TREMELLEN, K. P., KOLO, M., GILMORE, A., & LEKAMGE, D. N. (2005) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2005.00332.x · Cited by 194
Anti-Müllerian hormone as a predictor of IVF outcome
Lekamge, D. N., Barry, M., Kolo, M., Lane, M., Gilchrist, R. B., & Tremellen, K. P. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61053-x · Cited by 193
Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review
Al-Inany, H., Abou-Setta, A., & Aboulghar, M. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61059-0 · Cited by 185
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
Fauser, B. C. J. M. (1997) · Endocrine Reviews · doi:10.1210/er.18.1.71 · Cited by 179
Arce, J.-C., La Marca, A., Mirner Klein, B., Nyboe Andersen, A., & Fleming, R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.048 · Cited by 177
Self-citationDevelopment of a second generation anti-Müllerian hormone (AMH) ELISA
Kumar, A., Kalra, B., Patel, A., McDavid, L., & Roudebush, W. E. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.08.011 · Cited by 174
McIlveen, M., Skull, J., & Ledger, W. J. (2006) · Human Reproduction · doi:10.1093/humrep/del435 · Cited by 174
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction
Marca, A. L., Nelson, S. M., Sighinolfi, G., Manno, M., Baraldi, E., Roli, L., Xella, S., Marsella, T., Tagliasacchi, D., D’Amico, R., et al. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.11.005 · Cited by 173
Lainas, T. G., Sfontouris, I. A., Zorzovilis, I. Z., Petsas, G. K., Lainas, G. T., Alexopoulou, E., & Kolibianakis, E. M. (2009) · Human Reproduction · doi:10.1093/humrep/dep436 · Cited by 171
Ng, E. H. Y., Tang, O. S., & Ho, P. C. (2000) · Human Reproduction · doi:10.1093/humrep/15.9.1937 · Cited by 164
Frattarelli, J. L., Lauria-Costab, D. F., Miller, B. T., Bergh, P. A., & Scott, R. T. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00708-1 · Cited by 151
Uluğ, U., Ben‐Shlomo, I., Turan, E., Erden, H. F., Akman, M. A., & Bahçeci, M. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62164-5 · Cited by 146
Elgindy, E. A., El-Haieg, D. O., & El-Sebaey, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.040 · Cited by 146
The journey from the old to the new AMH assay: how to avoid getting lost in the values
Nelson, S. M., & Marca, A. L. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.06.011 · Cited by 141
Jayaprakasan, K., Chan, Y., Islam, R., Haoula, Z., Hopkisson, J. F., Coomarasamy, A., & Raine‐Fenning, N. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.05.042 · Cited by 138
Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?
Fong, S. L., Baart, E. B., Martini, E., Schipper, I., Visser, J., Themmen, A. P. N., de Jong, F., Fauser, B. C. J. M., & Laven, J. S. E. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60480-4 · Cited by 135
Ovarian follicular growth in humans: ovarian ageing and population of growing follicles
Gougeon, A. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00069-3 · Cited by 135
Gleicher, N., Weghofer, A., & Barad, D. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.067 · Cited by 134
Fréour, T., Mirallié, S., Bach‐Ngohou, K., Denis, M. G., Barrière, P., & Masson, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.06.013 · Cited by 131
Arslan, M., Bocca, S., Mirkin, S., Barroso, G., Stadtmauer, L., & Oehninger, S. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.02.053 · Cited by 126
Domar, A. D., Gordon, K., García-Velasco, J. A., Marca, A. L., Barrière, P., & Beligotti, F. (2012) · Human Reproduction · doi:10.1093/humrep/des016 · Cited by 122
Gougeon, A., & Lefèvre, B. (1983) · Reproduction · doi:10.1530/jrf.0.0690497 · Cited by 117
Pu, D., Wu, J., & Liu, J. (2011) · Human Reproduction · doi:10.1093/humrep/der240 · Cited by 114
Bancsi, L. F. J. M. M., Broekmans, F. J., Looman, C. W. N., Habbema, J. D. F., & Velde, E. R. T. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.06.011 · Cited by 114
A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II)
Wallace, A. M., Faye, S. A., Fleming, R., et al. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.010172 · Cited by 112
Riggs, R. M., Duran, E. H., Baker, M. W., Kimble, T., Hobeika, E. M., Yin, L., Matos-Bodden, L., Leader, B., & Stadtmauer, L. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.05.004 · Cited by 109
Jayaprakasan, K., Deb, S., Batcha, M., Hopkisson, J. F., Johnson, I. R., Campbell, B. K., & Raine‐Fenning, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.10.022 · Cited by 97
Medical hypophysectomy: II. Variability of ovarian response to gonadotropin therapy
Kenigsberg, D., Littman, B. A., Williams, R. F., et al. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47969-0 · Cited by 97
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period
Marca, A. L., Spada, E., Sighinolfi, G., Argento, C., Tirelli, A., Giulini, S., Milani, S., & Volpe, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.07.1069 · Cited by 96
Anckaert, E., Smitz, J. E. J., Schiettecatte, J., Klein, B. M., & Arce, J. (2012) · Human Reproduction · doi:10.1093/humrep/des101 · Cited by 94
Jayaprakasan, K., Hilwah, N., Kendall, N. R., Hopkisson, J. F., Campbell, B. K., Johnson, I. R., & Raine‐Fenning, N. (2007) · Human Reproduction · doi:10.1093/humrep/dem104 · Cited by 93
Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction
Al‐Azemi, M., Killick, S. R., Duffy, S., Pye, C., Refaat, B., Hill, N., & Ledger, W. J. (2010) · Human Reproduction · doi:10.1093/humrep/deq339 · Cited by 92
Yong, P. Y. K., Baird, D. T., Thong, K. J., McNeilly, A. S., & Anderson, R. A. (2003) · Human Reproduction · doi:10.1093/humrep/deg019 · Cited by 91
Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles
Öçal, P., Şahmay, S., Çetin, M., İrez, T., Güralp, O., & Çepni, İ. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9627-4 · Cited by 90
The ovarian reserve in mammals: A functional and evolutionary perspective
Monget, P., Bobe, J., Gougeon, A., Fabre, S., Monniaux, D., & Dalbiès‐Tran, R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.046 · Cited by 83
Lainas, T. G., Sfontouris, I. A., Papanikolaou, E. G., Zorzovilis, J. Z., Petsas, G. K., Lainas, G. T., & Kolibianakis, E. M. (2008) · Human Reproduction · doi:10.1093/humrep/den107 · Cited by 83
Ovulation induction in perspective
Homburg, R., & Insler, V. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.5.449 · Cited by 83
Live birth chances in women with extremely low-serum anti-Mullerian hormone levels
Weghofer, A., Dietrich, W., Barad, D. H., & Gleicher, N. (2011) · Human Reproduction · doi:10.1093/humrep/der134 · Cited by 75
Deb, S., Campbell, B. K., Clewes, J. S., Pincott‐Allen, C., & Raine‐Fenning, N. J. (2012) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.11226 · Cited by 71
Holte, J., Brodin, T., Berglund, L., Hadziosmanovic, N., Olovsson, M. H., & Bergh, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.06.071 · Cited by 71
Jayaprakasan, K., Campbell, B. K., Hopkisson, J. F., Clewes, J. S., Johnson, I. R., & Raine‐Fenning, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.028 · Cited by 69
Fleming, R., Deshpande, N., Traynor, I., & Yates, R. W. S. (2006) · Human Reproduction · doi:10.1093/humrep/dei499 · Cited by 69
Büyük, E., Seifer, D. B., Younger, J., Grazi, R. V., & Lieman, H. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.071 · Cited by 68
Poor responder protocols for in-vitro fertilization: options and results
Loutradis, D., Vomvolaki, E., & Drakakis, P. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328305b9b8 · Cited by 60
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception
Khader, A., Lloyd, S. M., McConnachie, A., Fleming, R., Grisendi, V., Marca, A. L., & Nelson, S. M. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-3 · Cited by 55
Jayaprakasan, K., Campbell, B. K., Hopkisson, J. F., Clewes, J. S., Johnson, I. R., & Raine‐Fenning, N. (2008) · Human Reproduction · doi:10.1093/humrep/den282 · Cited by 41
Satwik, R., Kochhar, M., Gupta, S. M., & Majumdar, A. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.101023 · Cited by 37
Nardo, L. G., Fleming, R., Howles, C. M., Bosch, E., Hamamah, S., Ubaldi, F. M., Hugues, J., Balen, A. H., & Nelson, S. M. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.05.008 · Cited by 36
Popovic-Todorovic, B., Loft, A. G., Ziebe, S., & Andersen, A. N. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.00573.x · Cited by 35
Yoo, J. H., Cha, S. H., Park, C. W., Kim, J. Y., Yang, K. M., Song, I. O., Koong, M. K., Kang, I. S., & Kim, H. O. (2011) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2011.38.4.222 · Cited by 33
Deb, S., Jayaprakasan, K., Campbell, B. K., Clewes, J. S., & Raine‐Fenning, N. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.031 · Cited by 27
Bonilla-Musoles, F. M., Castillo, J. C., Caballero, O., Pérez‐Panadés, J., Bonilla, F., Dolz, M., & Osborne, N. N. (2012) · PubMed · Cited by 24
Honnma, H., Baba, T., Sasaki, M., Hashiba, Y., 小栗, 久., Fukunaga, T., Endo, T., & Asada, Y. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9675-9 · Cited by 22
Ng, E. H. Y., Yeung, W. S. B., & Ho, P. C. (2005) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-005-6785-2 · Cited by 16
Lee, J. E., Lee, J. R., Jee, B. C., et al. (2012) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2012.39.4.176 · Cited by 15
Cited by
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
Testing and interpreting measures of ovarian reserve: a committee opinion
Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Hurd, W., Jindal, S., Kalra, S., Mersereau, J., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.09.134 · Cited by 617
Iliodromiti, S., Anderson, R. A., & Nelson, S. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu062 · Cited by 260
Fabregues, F., González-Foruria, I., Peñarrubia, J., & Carmona, F. (2018) · Human Reproduction · doi:10.1093/humrep/dey244 · Cited by 34
Metadata
- Authors
- La Marca, A., & Sunkara, S. K.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-29
- Volume
- 20
- Issue
- 1
- Pages
- 124-140
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2101304900
- Cited by
- 586
- References
- 99
- FWCI
- 36.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.